KMTS: Q1 revenue up 60% YoY, gross margin expands, FY 2027 guidance raised to $141M
Revenue grew 60% YoY to $31M with gross margin up to 56.5%, driven by market expansion, higher in-network mix, and operational leverage. FY 2027 revenue guidance was raised to $141M (48% growth), with gross margin targets increased to mid-70% over the next few years.Based on Kestra Medical Technolo…
5%, driven by market expansion, higher in-network mix, and operational leverage. Based on Kestra Medical Technolo…